The National Community Pharmacists Association on Wednesday rejected a proposed settlement in relation to the antitrust lawsuit that NCPA and other parties have brought against several banks regarding alleged collusive practices, including swipe fees at exorbitant levels and limiting competition.
Massachusetts lawmakers passed a massive healthcare bill that seeks to control healthcare costs and expands the services of limited-service clinics to allow for anything within the scope of practice for a nurse practitioner.
The National Association of Chain Drug Stores on Wednesday urged House and Senate leaders to support bipartisan legislation that would level the playing field between brick-and-mortar retail businesses — including community pharmacies — and Internet and other remote sellers.
As many as 47 million women will be gaining greater control over their health care and access to eight new prevention-related healthcare services without paying more out of their own pocket beginning Aug. 1, Health and Human Services secretary Kathleen Sebelius announced Tuesday.
In July, the country’s largest trade group representing the drug industry released a report showing nearly 200 drugs under clinical development or Food and Drug Administration review for treating mental disorders.
The Florida Pharmacy Association, together with a group of Medicaid patients, independent pharmacies and pharmacists from all over Florida, filed a lawsuit Thursday in Leon County Circuit Court against the Agency for Health Care Administration to seek to restore patient access to qualified Medicaid pharmacy providers.
A new study from Harvard School of Public Health found that expanding Medicaid to low-income adults led to improved health and reduced mortality. It is the first published study to look specifically at the effect of recent state Medicaid expansions on mortality among low-income adults.
Sens. Orrin Hatch, R-Utah, and Sheldon Whitehouse, D-R.I., on Wednesday introduced the Designer Anabolic Steroid Control Act, a bill that will protect consumers by providing the Drug Enforcement Administration with new enforcement tools to identify and quickly respond when new designer anabolic steroids are created and marketed as dietary supplements.
The Senate Committee on Commerce, Science and Transportation on Wednesday released a staff report on the investigation into the gray market for pharmaceuticals — what the committee defined as "shady operators who make enormous profits by buying hard-to-find drugs and reselling them at huge markups" — specifically naming pharmacies as a primary culprit.